Literature DB >> 18778234

Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.

Robert R Redfield, J Scott Morrow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778234     DOI: 10.1086/591802

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation.

Authors:  N J Liptrott; P Curley; D Moss; D J Back; S H Khoo; A Owen
Journal:  J Antimicrob Chemother       Date:  2013-06-21       Impact factor: 5.790

2.  The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.

Authors:  Kate Shearer; Matthew P Fox; Mhairi Maskew; Rebecca Berhanu; Lawrence Long; Ian Sanne
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.